A genome survey for novel Alzheimer disease risk loci: Results at 10-cM resolution

Genomics

Volumn 50, Issue 2, 1998, Pages 121-128

  Zubenko, George S ^a,b,c   Hughes, Hugh B ^a   Stiffler, J Scott ^a   Hurtt, Mark R ^a   Kaplan, Barry B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Carnegie Mellon University ^*  (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TANDEM REPEAT;

EID: 0032104204     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5306     Document Type: Article

References (77)

1. Nat. Genet. 11:1995;219-222.
2. Diagnostic and Statistical Manual of Mental Disorders. 1994;American Psychiatric Press, Washington.
3. Bachman D. L., Wolf P. A., Linn R., Knoefel J. E., Cobb J., Belanger A., D'Agostino R. B., White L. R. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology. 42:1992;115-119.
4. Bendotti C., Forloni G., Morgan R., O'Hara B. F., Oster-Granite L., Reeves R. H., Gearhart J. D., Coyle J. T. Neuroanatomical localization and quantification of amyloid precursor protein mRNA by in situ hybridization in the brains of normal, aneuploid and lesioned mice. Proc. Natl. Acad. Sci. USA. 85:1988;3628-3632.
5. Blessed G., Tomlinson B. E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. J. Psychiatr. 114:1968;797-811.
6. Brion S., Plas J., Jeanneau A. La maladie de Pick. Point de vue anatomo-clinique. Rev. Neurol. 147:1991;693-704.
7. Campion D., Flaman J.-M., Brice A., Hennequin D., Dubois B., Martin C., Moreau V., Charbonnier F., Didierjean O., Tardieu S., Pennet C., Puel M., Pasquier F., LeDoze F., Bellis G., Calenda A., Heilig R., Martinez M., Mallet J., Bellis M., Clerget-Darpoux F., Agid Y., Frebourg T. Mutations of the presenilin 1 gene in families with early-onset Alzheimer's disease. Hum. Mol. Genet. 4:1995;2373-2377.
8. Chakravarti A., Slaugenhaupt S., Zubenko G. S. Inheritance pattern of platelet membrane fluidity in Alzheimer's disease. Am. J. Hum. Genet. 44:1989;799-805.
9. Chartier-Harlin M.-C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J., Mullan M. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature. 353:1991;844-846.
10. Chartier-Harlin M.-C., Parfitt M., Legrain S., Perez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourle V., Fruchart J.-C., Delacourte A., Rossor M., Amouyel P. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3:1994;569-574.
11. Chen X., Xia Y., Alford M., DeTeresa R., Hansen L., Klauber M. R., Katzman R., Thal L., Masliah E., Saitoh T. The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease. Ann. Neurol. 38:1995;653-658.
12. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type-4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
13. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C. Jr., Immler J. B., Locke P. A., Conneally P. M., Schmader K. E. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nat. Genet. 7:1994;180-184.
14. Cruts M., Backhovens H., Wang Y., Gassen G. V., Theuns J., DeJonghe C., Wehnert A., DeVoecht J., DeWinter G., Cras P., Bruyland M., Datson N., Weissenbach J., den Dunnen J. T., Martin J.-J., Hendriks L., van Broeckhoven C. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum. Mol. Genet. 4:1995;2363-2371.
15. Dai X. Y., Nanko S., Hattori M., Fukuda R., Nagata K., Isse K., Ueki A., Kazamatsuri H. Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci. Lett. 175:1994;74-76.
16. Daniel S. E., Lees A. J. Parkinson's Disease Society Brain Bank, London: Overview and research. J. Neural Transm. 39:1993;165-172.
17. Dickson D. W., Crystal H., Mattiace L. A., Kress Y., Schwagerl A., Ksiezak-Reding H., Davies P., Yen S. H. Diffuse Lewy body disease: Light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol. 78:1989;572-584.
18. Evans D. A., Funkenstein H. H., Albert M. S., Scherr P. A., Cook N. R., Chown M. J., Hebert L. E., Hennekens C. H., Taylor J. O. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. J. Am. Med. Assoc. 262:1989;2551-2556.
19. Folstein M. F., Folstein S. E., HcHugh P. R. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
20. Human Genome Database (GDB), 1998, Johns Hopkins University, Baltimore, MD, 1990-present, http://www.gdb.org/ , http://www.gdb.org/.
21. Goate A. M., Chartier-Harlin C. M., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
22. Hagnell O., Ojejo L., Rorsman B. Incidence of dementia in the Lunby study. Neuroepidemiology. 11:1992;61-66.
23. Hansen L., Salmon D., Galasko D., Masliah E., Katzman R., DeTeresa R., Thal L., Pay M. M., Hofstetter R., Klauber M., Rice V., Butters N., Alford M. The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity. Neurology. 40:1990;1-8.
24. Hendrie H. C., Hall K. S., Hui S., Unverzagt F. W., Yu C. E., Lahiri D. K., Sahota A., Farlow M., Msick B., Class C. A. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann. Neurol. 37:1995;118-120.
25. Hixson J. E., Vernier D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage withHha. J. Lipid Res. 31:1990;545-548.
26. Holland A. J. Down's syndrome and dementia of the Alzheimer type. Dementia. 1994;Chapman and Hall, London. p. 695-708.
27. Jones E. W. Proteinase mutants ofSaccharomyces cerevisiae. Genetics. 85:1977;23-33.
28. Jonsson J. J., Weissman S. M. From mutation mapping to phenotype cloning. Proc. Natl. Acad. Sci. USA. 92:1995;83-85.
29. Jorm A. F., Korten A. E., Henderson A. S. The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr. Scand. 7:1987;465-479.
30. Khachaturian Z. S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
31. Kokmen E., Beard C. M., Offord K. P., Kurland L. T. Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975. Neurology. 39:1989;773-776.
32. Lander E. S., Schork N. J. Genetic dissection of complex traits. Science. 265:1994;2037-2048.
33. LeDuc C., Miller P., Lichter J., Parry P. Batched analysis of genotypes. PCR Methods and Applications. 1993;Cold Spring Harbor Laboratory Press, New York. p. 331-336.
34. Levy-Lahad E., Wijsman E. M., Nemens E., Anderson L., Goddard K. A. B., Weber J. L., Bird T. D., Schellenberg G. D. A familial Alzheimer's disease locus on chromosome 1. Science. 269:1995a;970-973.
35. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C.-E., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y.-H., Guenette S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., Tanzi R. E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995b;973-977.
36. Lippa C. F., Smith T. W., Swearer J. M. Alzheimer's disease and Lewy body disease: A comparative clinicopathological study. Ann. Neurol. 35:1994;81-88.
37. Maestre G., Ottman R., Stern Y., Gurland B., Chun M., Tang M. X., Shelanski M., Tycko B., Mayeux J. R. Apolipoprotein E and Alzheimer's disease: Ethnic variation in genotypic risks. Ann. Neurol. 37:1995;254-259.
38. Miller S. A., Cykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
39. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain C. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Neurology. 41:1991;479-486.
40. Mullan M., Crawford F., Axelman K., Houlden H., Lulius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat. Genet. 1:1992;345-347.
41. Murrell J., Farlow M., Ghetti B., Benson M. D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 254:1991;97-99.
42. Myklebost O., Rogne S. A physical map of the apolipoprotein gene cluster on human chromosome 19. Hum. Genet. 78:1988;244-247.
43. Nechiporuk A., Fain P., Kort E., Nee L. E., Frommelt E., Polinsky R. J., Korenberg J. R., Pulst S. M. Linkage of familial Alzheimer disease to chromosome 14 in 2 large early-onset pedigrees: Effects of marker allele frequencies on LOD scores. Am. J. Med. Genet. 48:1993;63-66.
44. Science. 258:1992;67-86.
45. Noguchi S., Murakami K., Yamada N. Apolipoprotein-E genotype and Alzheimer's disease. Lancet. 342:1993;737.
46. Okuizumi K., Onodera O., Tanaka H., Kobayashi H., Tsuji S., Takahashi H., Oyanagi K., Seki K., Tanaka M., Naruse S. ApoE-epsilon 4 and early-onset Alzheimer's. Nat. Genet. 7:1994;10-11.
47. Oppenheimer D. R., Esiri M. M. Diseases of the basal ganglia, cerebellum and motor neurons. Parkinson's disease (paralysis agitans). Adams J. H., Duchen L. W. Greenfield's Neuropathology. 1992;991-997 Oxford Univ. Press, New York.
48. Pacek P., Sajantila A., Syvänen A.-C. Determination of allele frequencies at loci with length polymorphism by quantitative analysis of DNA amplified from pooled samples. PCR Methods and Applications. 1993;Cold Spring Harbor Laboratory Press, New York. p. 313-317.
49. Pericak-Vance M. A., Haines J. L. Genetic susceptibility to Alzheimer's disease. Trends Genet. 11:1995;504-508.
50. Pericak-Vance M. A., Bass M. P., Yamaoka L. H., Gaskell P. C., Scott W. K., Terwedow H. A., Menold M. M., Conneally P. M., Small G. W., Vance J. M. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. J. Am. Med. Assoc. 278:1997;1237-1241.
51. Rebeck G. W., Reiter J. S., Strickland D. K., Hyman B. T. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron. 11:1993;575-580.
52. Rocca W. A., Amaducci L. A., Schoenberg B. S. Epidemiology of clinically diagnosed Alzheimer's disease. Ann. Neurol. 19:1986;415-424.
53. Rogaev E. I., Sherrington R., Rogaeva E. A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumaker I., Cohen D., Lannfelt L., Fraser P. E., Rommens J. M., St. George-Hyslop P. H. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
54. Rumble B., Retallack R., Hilbich C., Simms G., Multhaup G., Martins R., Hockey A., Montgomery P., Beyreuther K., Masters C. L. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320:1989;1446-1452.
55. Sahara N., Yahagi Y.-I., Takagi H., Kondo T., Okochi M., Susami M., Shirasawa T., Mari H. Identification and characterization of presenilin I-467, I-463, and I-374. FEBS Lett. 381:1996;7-11.
56. Saitoh T., Xia Y., Chen X., Masliah E., Glaasko D., Shults C., Thai L. J., Hansen L. A., Katzman R. The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Ann. Neurol. 37:1995;110-112.
57. Saunders A. M., Strittmatter W. J., Schmechel D., St. George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-McLachlan D. R., Alberts M. J., Hulette C., Crain B., Goldgaber D., Roses A. D. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
58. Schellenberg G. D., Bird T. D., Wijsman E. M., Orr H. T., Anderson L., Nemens E., White J. A., Bonnycastle L., Weber J. L., Alonso M. E., Potter H., Heston L. L., Martin G. M. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 258:1992;668-671.
59. Schmechel D., Saunders A., Strittmatter W., Crain B. J., Hulette C. M., Joo S. H., Pericak-Vance M. A., Goldgaber D., Roses A. D. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;9649-9653.
60. Sherrington R., Govaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikdea M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A. C., Montesi M. P., Sorbi S., Rainero I., Piness L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R. J., Wasco W., DaSilva H. A. R., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P. E., Rommens J. M., St. George-Hyslop P. H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
61. Spatz H. La maladie de Pick, les atrophies systématisées progressives et la sénescence cérébrale prématurée localisce. The Proceedings of the First International Congress of Neuropathology. 1952;Rosenberg and Sellier, Torino. p. 375-406.
62. St. George-Hyslop P., Haines J., Rogaev E., Mortilla M., Vaula G., Pericak-Vance M., Foncin J.-F., Montesi M., Bruni A., Sorbi S. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat. Genet. 2:1992;330-334.
63. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
64. Terwilliger J. D. A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am. J. Hum. Genet. 56:1995;777-787.
65. Tissot R., Constantinidis J., Richard J. La maladie de Pick. 1975;Masson, Paris. p. 1-222.
66. Ueki A., Kawano M., Namba Y., Kawakami M., Ikeda K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci. Lett. 163:1993;166-168.
67. van Broeckhoven C., Backhovens H., Cruts M., de Winter G., Bruyland M., Cras P., Martin J. J. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat. Genet. 2:1992;335-339.
68. van Duijn C. M., de Knijff P., Cruts M., Wehner A., Havekes L. M., Hofman A., Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat. Genet. 7:1994;74-78.
69. Weeks D. E., Lathrop G. M. Polygenic disease: Methods for mapping complex disease traits. Trends Genet. 11:1995;513-519.
70. Wragg M., Hutton M., Talbot C. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet. 347:1996;509-512.
71. Yan S. D., Fu J., Soto C., Chen X., Zhu H., Al-Mohanna F., Collison K., Zhu A., Stern E., Saido T., Tohyama M., Ogawa S., Roher A., Stern D. An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease. Nature. 389:1997;689-695.
72. Yoshizawa T., Yamakawkobayashi K., Komatsuzaki Y., Arinami T., Oguni E., Mizusawa H., Shoji S., Hamaguchi H. Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease. Ann. Neurol. 36:1994;656-659.
73. Zhang M., Katzman R., Salmon D., Jin H., Cai G., Wang Z., Qu G., Grant I., Yu E., Levy P., Klauber M. R., Liu W. T. The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education. Ann. Neurol. 27:1990;428-437.
74. Zubenko G. S., Stiffler S., Kopp U., Hughes H., Kaplan B. B., Moossy J. Lack of variation in the nucleotide sequence corresponding to the transmembrane domain of the β-amyloid precursor protein in Alzheimer's disease. Am. J. Med. Genet. (Neuropsychiatr. Genet.). 48:1993;131-136.
75. Zubenko G. S., Stiffler S., Stabler S., Kopp U., Hughes H. B., Cohen B. M., Moossy J. Association of the apolipoprotein E ε4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am. J. Med. Genet. (Neuropsychiatr. Genet.). 54:1994;199-205.
76. Zubenko G. S. Molecular neurobiology of Alzheimer's disease (syndrome?). Harvard Rev. Psychiatr. 5:1997;1-37.
77. Zubenko G. S., Stiffler J. S., Hughes H. B., Hurtt M. R., Kaplan B. B. Initial results of a genome survey for novel Alzheimer's disease risk genes: Association with a locus on the X-chromosome. Am. J. Med. Genet. (Neuropsychiatr. Genet.). 81:1998;196-205.